Employees Retirement System of Texas reduced its stake in STERIS PLC (NYSE:STE) by 11.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 56,000 shares of the medical equipment provider’s stock after selling 7,000 shares during the period. Employees Retirement System of Texas owned 0.07% of STERIS PLC worth $4,564,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Citigroup Inc. bought a new stake in shares of STERIS PLC during the second quarter valued at approximately $206,000. Van Cleef Asset Management Inc bought a new stake in shares of STERIS PLC during the second quarter valued at approximately $208,000. Cigna Investments Inc. New bought a new stake in shares of STERIS PLC during the second quarter valued at approximately $209,000. BT Investment Management Ltd bought a new stake in shares of STERIS PLC during the second quarter valued at approximately $210,000. Finally, Allegis Investment Advisors LLC bought a new stake in shares of STERIS PLC during the second quarter valued at approximately $251,000. Institutional investors own 93.33% of the company’s stock.

A number of research firms have recently weighed in on STE. Zacks Investment Research raised STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price target on the stock in a report on Tuesday, July 11th. BidaskClub cut STERIS PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Raymond James Financial, Inc. lifted their price target on STERIS PLC from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, August 9th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. STERIS PLC presently has a consensus rating of “Buy” and an average target price of $86.75.

In other news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $85.69, for a total transaction of $856,900.00. Following the sale, the chief executive officer now directly owns 83,270 shares of the company’s stock, valued at $7,135,406.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Mohsen Sohi sold 2,744 shares of the stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total transaction of $235,929.12. Following the sale, the director now directly owns 21,816 shares in the company, valued at $1,875,739.68. The disclosure for this sale can be found here. Insiders have sold 194,086 shares of company stock worth $16,953,621 over the last three months. 2.55% of the stock is owned by insiders.

Shares of STERIS PLC (STE) opened at 90.51 on Friday. The stock’s 50 day moving average price is $87.07 and its 200-day moving average price is $79.97. STERIS PLC has a 12-month low of $63.80 and a 12-month high of $91.18. The company has a market cap of $7.71 billion, a PE ratio of 64.74 and a beta of 1.29.

STERIS PLC (NYSE:STE) last issued its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.80 by $0.05. The firm had revenue of $608.00 million for the quarter, compared to analysts’ expectations of $597.66 million. STERIS PLC had a net margin of 4.63% and a return on equity of 11.39%. The company’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.79 earnings per share. On average, equities research analysts forecast that STERIS PLC will post $4.06 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th were paid a dividend of $0.31 per share. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a dividend yield of 1.37%. The ex-dividend date was Friday, August 25th. STERIS PLC’s dividend payout ratio is 88.57%.

WARNING: This article was originally published by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/employees-retirement-system-of-texas-decreases-holdings-in-steris-plc-ste/1615331.html.

STERIS PLC Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).

Institutional Ownership by Quarter for STERIS PLC (NYSE:STE)

Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.